Show simple item record

dc.contributor.authorMaheshwari, Rahulen
dc.contributor.authorTekade, Muktikaen
dc.contributor.authorGondaliya, Piyushen
dc.contributor.authorKalia, Kiranen
dc.contributor.authorD’Emanuele, Antonyen
dc.contributor.authorTekade, Rakesh Kumaren
dc.date.accessioned2018-11-08T14:29:06Z
dc.date.available2018-11-08T14:29:06Z
dc.date.issued2017-09-29
dc.identifier.citationMaheshwari, R. Tekade, M., Gondaliya, P., Kalia, K., D’Emanuele, A., Tekade, R.K. (2017) Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers. Nanomedicine, 12 (21), pp. 2653-2675.en
dc.identifier.issn1743-5889
dc.identifier.urihttp://hdl.handle.net/2086/17128
dc.description.abstractRNA interference (RNAi) therapeutics (siRNA, miRNA, etc.) represent an emerging medicinal remedy for a variety of ailments. However, their low serum stability and low cellular uptake signi cantly restrict their clinical applications. Exosomes are biologically derived nanodimensional vesicle ranging from a few nanometers to a hundred. In the last few years, several reports have been published demonstrating the emerging applications of these exogenous membrane vesicles, particularly in carrying different RNAi ther- apeutics to adjacent or distant targeted cells. In this report, we explored the numerous aspects of exosomes from structure to clinical implications with special emphasis on their application in delivering RNAi-based therapeutics. siRNA and miRNA have attracted great interest in recent years due to their speci c applica- tion in treating many complex diseases including cancer. We highlight strategies to obviate the challenges of their low bioavailability for gene therapy.en
dc.language.isoenen
dc.publisherFutureMedicineLtden
dc.subjectRNAien
dc.subjectclinical trialsen
dc.subjectexosomal proteinsen
dc.subjectexosomesen
dc.subjectgene silencingen
dc.subjectgene therapyen
dc.subjectgenetic diseasesen
dc.subjectnanocarriersen
dc.subjectpatentsen
dc.titleRecent advances in exosome-based nanovehicles as RNA interference therapeutic carriersen
dc.typeArticleen
dc.identifier.doihttps://doi.org/10.2217/nnm-2017-0210
dc.peerreviewedYesen
dc.funderN/Aen
dc.projectidN/Aen
dc.cclicenceCC-BY-NC-NDen
dc.date.acceptance2017-09-01en
dc.exception.reasonFull text not deposited within 3 months of acceptanceen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record